menu
    • menu

    Company profile for Notch Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer. Notch has developed a next-generation approach to producing uniform, stem cell-derived, gene-edited immune cell therapies on a large scale by mimicking ...
    Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer. Notch has developed a next-generation approach to producing uniform, stem cell-derived, gene-edited immune cell therapies on a large scale by mimicking the “niche” of the human thymus, where T cells originate.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Notch TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    40 King Street West, Suite 2100 Toronto, Ontario M5H 3C2
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://notchtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/notch
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Notch begins 'significant' layoffs, blames tough environment
    Notch begins 'significant' layoffs, blames tough environment

    17 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/notch-begins-significant-layoffs-blames-tough-environment-cell-therapy-biotechs

    FIERCE BIOTECH
    17 Jan 2025
    Share Share
    Notch Therapeutics Enhances Cell Therapy Expertise with Updates
    Notch Therapeutics Enhances Cell Therapy Expertise with Updates

    08 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/notch-therapeutics-enhances-cell-therapy-expertise-with-updates-to-scientific-advisory-board-301671124.html

    PRNEWSWIRE
    08 Nov 2022
    Share Share
    Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline
    Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline

    10 Feb 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/notch-therapeutics-closes-85-million-series-a-financing-to-develop-pipeline-of-renewable-stem-cell-derived-cancer-immunotherapies-301225645.html

    PRNEWSWIRE
    10 Feb 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search